Published by
AFP
AFP
Washington (AFP) – Pfizer said Monday it had begun a middle-to-late stage clinical trial of a pill to stave off Covid in people who are exposed to infection. Several companies are working on so-called oral antivirals, which would mimic what the drug Tamiflu does for influenza and prevent the disease from progressing to severe. “We believe that tackling the virus will require effective treatments for people who contract, or have been exposed to, the virus, complementing the impact that vaccines have had,” said Mikael Dolsten, the company’s chief scientific officer. Pfizer started developing its…
